
Xonmed SB 250mg/125mg Injection
Marketer
Medlock Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Xonmed SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby limiting infection spread. Administration must be solely under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, regardless of symptom improvement. Premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Prior to commencing treatment, inform your physician of all current medications. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to potential increased somnolence. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order laboratory tests to monitor treatment response.
Primary Ingredients of Xonmed SB 250mg/125mg Injection
No text provided to rephrase.
Uses of Xonmed SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Xonmed SB 250mg/125mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Xonmed SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xonmed SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Xonmed SB 250mg/125mg Injection works:
Ceftriaxone/Sulbactam injection (Xonmed SB, 250mg/125mg) unites two active agents. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. The beta-lactamase inhibitor, sulbactam, counters bacterial resistance mechanisms, thus boosting ceftriaxone's antimicrobial effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Xonmed SB 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xonmed SB, 250mg/125mg, is typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scant.
Breast feedingCAUTION
Administering Xonmed SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Xonmed SB 250mg/125mg Injection could lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xonmed SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Xonmed SB 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Xonmed SB 250mg/125mg Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xonmed SB 250mg/125mg Injection :
Should you forget a dose of Xonmed SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Xonmed SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
